Emily J Culme-Seymour

Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study

Francesca Ferrua, Maria Pia Cicalese, Stefania Galimberti et al. · The Lancet Haematology · 2019 · 200 citations · Full text

Tissue-Engineered Tracheal Replacement in a Child: A 4-Year Follow-Up Study

Nicholas Hamilton, Mazyar Kanani, Derek Roebuck et al. · American Journal of Transplantation · 2015 · 175 citations · Full text

Tissue Engineering, Lung Transplantation, Engineering +18

A Decade of Cell Therapy Clinical Trials (2000–2010)

Emily J Culme-Seymour, Natasha L. Davie, David Brindley et al. · Regenerative Medicine · 2012 · 66 citations

Cell Therapy, Cellular Therapies, Medicine +6

Study Design: Human Leukocyte Antigen Class I Molecule A∗02-Chimeric Antigen Receptor Regulatory T Cells in Renal Transplantation

Katharina Schreeb, Emily J Culme-Seymour, Essra Ridha et al. · Kidney International Reports · 2022 · 57 citations · Full text

Cost of Stem Cell-Based Tissue-Engineered Airway Transplants in the United Kingdom: Case Series

Emily J Culme-Seymour, Katrina Mason, Laura Vallejo‐Torres et al. · Tissue Engineering Part A · 2015 · 24 citations

Tissue Engineering, Engineering, Case Series +16